A new parameter in COVID-19 pandemic: initial lactate dehydrogenase (LDH)/Lymphocyte ratio for diagnosis and mortality
- PMID: 33071210
- PMCID: PMC7526632
- DOI: 10.1016/j.jiph.2020.09.009
A new parameter in COVID-19 pandemic: initial lactate dehydrogenase (LDH)/Lymphocyte ratio for diagnosis and mortality
Abstract
Background: COVID-19 (Coronavirus Disease-2019) is a pandemic disease, infecting more than 26.5 million people. Since there is no specific and effective treatment; early diagnosis and optimal isolation of the patient are of vital importance. Real-time polymerase chain reaction-based (RT-PCR) analyses do not achieve sufficient sensitivity in the diagnosis of the disease.
Methods: The data from 2217 patients diagnosed as COVID-19 between March 2020 and June 2020 and hospitalized or discharged with home isolation were retrospectively analyzed. Demographic data, comorbidities, PCR results, initial computed tomography (CT), laboratory values, Lactate Dehydrogenase (LDH)/Lymphocyte ratio, initial treatments and last status were recorded. The diagnostic sensitivity of LDH/Lymphocyte ratio, which is the main purpose of the study, was analyzed statistically.
Results: In order to test the effectiveness of LDH/Lymphocyte ratio for COVID-19 for diagnostic purposes, CT results were considered as gold standard. The area under the curve (AUC) was found to be 0.706 (p < 0.001; cut-off > 0.06) (Sensitivity: 76.4, specificity: 59.60). For the evaluation of LDH/Lymphocyte ratio in terms of survival, AUC was found to be 0.749 (p < 0.001; cut-off > 0.21) (Sensitivity: 70.59, specificity: 73.88).
Conclusion: Studies based on radiological findings have demonstrated that CT involvement has higher sensitivity. LDH/Lymphocyte ratio was analyzed in terms of diagnosis and mortality with using specific CT involvement as gold standard method which was found to be a more sensitive due to PCR false negativity; 0.06 and 0.21 were obtained as cut off values for diagnosis and mortality.
Keywords: COVID- 19; Diagnosis; LDH/Lymphocyte ratio; Mortality; Sensitivity.
Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Similar articles
-
Evaluation of Routine Blood Tests for Diagnosis of Suspected Coronavirus Disease 2019.Clin Lab. 2020 Sep 1;66(9). doi: 10.7754/Clin.Lab.2020.200522. Clin Lab. 2020. PMID: 32902237
-
IL-6-based mortality risk model for hospitalized patients with COVID-19.J Allergy Clin Immunol. 2020 Oct;146(4):799-807.e9. doi: 10.1016/j.jaci.2020.07.009. Epub 2020 Jul 22. J Allergy Clin Immunol. 2020. PMID: 32710975 Free PMC article.
-
Rapid identification of SARS-CoV-2-infected patients at the emergency department using routine testing.Clin Chem Lab Med. 2020 Jun 29;58(9):1587-1593. doi: 10.1515/cclm-2020-0593. Print 2020 Aug 27. Clin Chem Lab Med. 2020. PMID: 32598302
-
Thoracic imaging tests for the diagnosis of COVID-19.Cochrane Database Syst Rev. 2020 Sep 30;9:CD013639. doi: 10.1002/14651858.CD013639.pub2. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2020 Nov 26;11:CD013639. doi: 10.1002/14651858.CD013639.pub3. PMID: 32997361 Updated.
-
Diagnostic Tools for Coronavirus Disease (COVID-19): Comparing CT and RT-PCR Viral Nucleic Acid Testing.AJR Am J Roentgenol. 2020 Oct;215(4):834-838. doi: 10.2214/AJR.20.23418. Epub 2020 May 15. AJR Am J Roentgenol. 2020. PMID: 32412790 Review.
Cited by
-
Assessment of Some Risk Factors and Biological Predictors in the Post COVID-19 Syndrome in Asthmatic Patients.J Pers Med. 2023 Dec 22;14(1):21. doi: 10.3390/jpm14010021. J Pers Med. 2023. PMID: 38248722 Free PMC article.
-
A Review of Routine Laboratory Biomarkers for the Detection of Severe COVID-19 Disease.Int J Anal Chem. 2022 Oct 11;2022:9006487. doi: 10.1155/2022/9006487. eCollection 2022. Int J Anal Chem. 2022. PMID: 36267156 Free PMC article. Review.
-
Coronary heart disease and COVID-19: A meta-analysis.Med Clin (Engl Ed). 2021 Jun 11;156(11):547-554. doi: 10.1016/j.medcle.2020.12.021. Epub 2021 Jun 5. Med Clin (Engl Ed). 2021. PMID: 34109276 Free PMC article.
-
Prognostic Value of a Novel Parameter in Patients with Infective Endocarditis.Biomed Res Int. 2022 Apr 13;2022:1042780. doi: 10.1155/2022/1042780. eCollection 2022. Biomed Res Int. 2022. PMID: 35463994 Free PMC article.
-
The Role of Aspartate Aminotransferase-to-Lymphocyte Ratio Index (ALRI) in Predicting Mortality in SARS-CoV-2 Infection.Microorganisms. 2023 Nov 30;11(12):2894. doi: 10.3390/microorganisms11122894. Microorganisms. 2023. PMID: 38138038 Free PMC article.
References
-
- Centers for Disease Control and Prevention. People Who Are at Higher Risk for Severe Illness. 2020; https://www.cdc.gov/coronavirus/2019-ncov/need- extra-precautions/people.... Accessed April 8, 2020.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical